Volkswagen Q1 Profit Climbs, Deliveries Down; Sees Higher Revenues In FY22

volkswagen may04 lt

German automaker Volkswagen AG reported Wednesday significantly higher profit in its first quarter, while sales revenues were nearly flat and deliveries declined due to parts and supply shortages amid the ongoing Russia-Ukraine conflict.

Looking ahead for fiscal 2022, the company projects higher sales revenue and vehicle deliveries. In Germany, Volkswagen shares were losing around 1 percent.

The company sees 5 percent-10 percent year-over-year growth in vehicle deliveries in 2022. The company expects the supply of semiconductors will improve in the second half of the year, compared with the first half.

Further, the company expects sales revenue for Volkswagen group and of the Passenger Cars Business Area in 2022 to be 8 percent-13 percent higher than the prior year. The company projects an operating return on sales in the range of 7.0 percent to 8.5 percent in 2022.

Sales volume in the markets for passenger cars and light commercial vehicles in North America in 2022 is forecast to be slightly higher than the previous year's level.

Overall, the global volume of new vehicle sales is expected to be slightly up on the prior year without reaching the pre-pandemic level.

For 2022, the company expects an overall slightly positive development in new registrations for mid-sized and heavy trucks with a gross weight of more than six tonnes compared with the previous year, with variations from region to region.

For the first quarter, earnings attributable to shareholders surged to 6.56 billion euros or 13.05 euros per share from 3.24 billion euros or 6.45 euros per share in the previous year.

Earnings before tax were 8.90 billion euros in the first quarter, 99.3 percent higher than 4.46 billion euros in the same quarter a year ago.

Operating result grew 73 percent year-over-year to 8.32 billion euros, and operating margin improved to 13.3 percent from 7.7 percent a year ago.

Sales revenue edged up 0.6 percent to 62.742 billion from prior year's 62.376 billion euros.

Volkswagen said deliveries in the quarter were down 21.9 percent to 1.90 million units from prior year's 2.43 million units.

The shortage of semiconductors and the disruption of supply chains caused by the Russia-Ukraine conflict as well as the Covid-19 pandemic hurt the results.

Passenger cars deliveries fell 22.8 percent from last year to 1.83 million units, while sales in Commercial vehicles business area grew 12.3 percent to 67.76 thousand units.

The company recorded weak deliveries across all regions. In Germany, vehicle deliveries were down 5.3 percent, while the drop was 26.7 percent in Noth America.

Vehicle sales dropped 14.5 percent from last year to 2 million units, and production declined 12 percent to 2.04 million units. Production outside Germany dropped 10.1 percent.

In the quarter, share of all-electric vehicles grew to 5.2 percent of total deliveries, compared to 2.5 percent a year ago.

In Germany, Volkswagen shares were trading at 204.90 euros, down 0.82 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
Follow RTT